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Abstract: There is considerable attention directed at chemically modifying nucleic acids 
with robust functional groups in order to alter their properties. Since the breakthrough of 
copper-assisted azide-alkyne cycloadditions (CuAAC), there have been several reports 
describing the synthesis and properties of novel triazole-modified nucleic acid derivatives 
for potential downstream DNA- and RNA-based applications. This review will focus on 
highlighting representative novel nucleic acid molecular structures that have been 
synthesized via the “click” azide-alkyne cycloaddition. Many of these derivatives show 
compatibility for various applications that involve enzymatic transformation, nucleic   
acid hybridization, molecular tagging and purification, and gene silencing. The details of 
these applications are discussed. In conclusion, the future of nucleic acid analogues 
functionalized with triazoles is promising. 
Keywords: click chemistry; triazole; CuAAC; nucleic acids; oligonucleotides; 
bioconjugation; copper-catalyzed; Huisgen dipolar cycloaddition; azide; alkyne 
 
1. Introduction 
Since its discovery by Meldal and Sharpless in 2001 [1], the Cu(I)-catalyzed adaptation of 
Huisgen’s 1,3-dipolar [3 + 2] azide-alkyne (CuAAC) cycloaddition has not only earned the title of 
“click” reaction, but has nearly become synonomous with the term due its speed, versatility, simplicity 
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and its broad applications [2–5]. This particular click cycloaddition has had a considerable impact  
on chemical transformations leading to the production of new materials [6,7] and libraries of   
molecules with applications in biological systems [3]. The CuAAC reaction is an ideal bioorthogonal 
transformation because it can be performed under various environmental conditions, is high-yielding 
and expedient, the azide and alkyne moieties are physiologically inert [8], and the regio- and 
stereospecificity of the triazole product are tightly controlled [1]. 
In order to form ideal candidates for pharmaceuticals and novel biological research tools, nucleic 
acids and their oligomers often benefit from chemical modification. For oligonucleotides, chemical 
modification can be used to mitigate certain problematic features inherent in their native structure such 
as the polyanionic backbone and their susceptibility to nuclease-mediated cleavage [9]. In addition, 
chemical modification can be used to append novel functionalities on the nucleic acid molecule for 
other downstream biological applications. Such applications include, but are not limited to the field of 
molecular diagnostics which encompasses the synthesis of DNA microarrays [10–12], molecular 
probes [13,14], antisense oligonucleotides (ASOs) [15,16], and short-interfering RNAs (siRNAs) [17–19]. 
In addition, nucleic acid derivatives are constantly being designed, synthesized and modified for use as 
antiviral and anti-tumor therapies, and for the regulation of gene expression. Antiviral nucleoside 
analogues (ANAs), ASOs and siRNAs have been researched as potential therapeutic agents to 
overcome viral infections [20–22], or the expression of problematic genes in diseased cells [23]. There 
are examples of ANAs and ASOs which are commercially available [24,25], whereas the pursuit of 
siRNAs exhibiting properties which present them as viable pharmaceutical candidates is still 
underway. Some other examples of emerging biologically active nucleic acid derivatives include 
synthetic ribozymes [26], unique aptamers [27,28], and triplex forming oligonucleotides (TFOs) [29]. 
Due to their structure, there are three main areas within nucleic acids which are commonly altered 
through chemical modification: the ribose sugar, the nitrogenous base, and the phosphodiester 
internucleotide linkage. Although there are many examples of chemical transformations being used to 
modify nucleic acid residues, click chemistry is becoming ubiquitous in its ability to modify these 
three main areas with relative ease.  
According to the literature, most click-mediated modifications are performed on the nitrogenous 
bases by introducing novel base analogues [30–33], attaching fluorophores or isotopic elements for 
molecular imaging [34–37], forming inter-strand linkages between oligonucleotides [38–40], and the 
bioconjugation of molecules used for the assisted delivery of nucleic acid-based therapies [41].   
There are, however, fewer studies focused on altering the native backbone due to the complexity  
and multi-step fashion of the proposed synthetic strategies and the reactivity of certain alterations to 
the automated process of synthesizing designer oligonucleotides [42]. Click chemistry has given 
researchers the opportunity to target the backbone using a fairly simple synthetic procedure, with the 
goal of negating the effects imposed on nucleic acid derivatives which stem from the problematic 
backbone. Knowing that the polyanionic structure of the native phosphodiester linkage is one of the main 
problems faced by oligonucleotides trying to emerge on the market as therapeutic agents [17,19,23], 
click chemistry can introduce a neutrally-charged and physiologically stable heterocycle at this site. 
That being said, most modifications performed on all three key areas of nucleic acids are done so in 
order to increase the bioavailability of nucleic acid-based therapies and to reduce their toxicity, all 
while maintaining their potency. Molecules 2012, 17  12667 
 
In this review we will be documenting the development of click-modified nucleic acid derivatives 
and their applications in both biological, and non-biological systems. The literature chosen for this 
review succeeds what was extensively covered by Amblard and colleagues in 2009 [2] and serves to 
compliment the review by El-Sagheer and Brown in 2010 [8] with current and novel triazole-modified 
ribo- and 2′-deoxyribonucleic acid compounds. 
2. Click Modification of Nucleic Acids 
2.1. Nitrogenous Bases  
Nucleobases are the most frequently modified portions of nucleic acids due to the presence of easily 
modifiable sites, shorter synthetic routes for their modification, and the functional versatility of the 
derivatized products [36,43]. In the form of nucleotide phosphoramidite building blocks typically used 
to chemically synthesize DNA and RNA oligonucleotides through an automated process [44,45], 
nucleobase analogues can be site-specifically incorporated throughout the oligomer. Similarly, 
nucleotide sugar or backbone modifications can be incorporated into synthetic oligonucleotides using 
this process. However, unlike certain modified sugars or phosphates, all modified nucleobases have the 
advantage of unrestricted positioning throughout growing polynucleotides [46]. In addition, modified 
nucleobases can influence the major or minor grooves within DNA and RNA duplexes [47,48] while 
maintaining direct Watson-Crick interactions [43,49]. Certain nucleobase-modified DNA and   
RNA-based probes have been reported to hybridize to their targets with increased accuracy and 
mismatch discrimination [32,35]. Furthermore, the potency of oligonucleotides designed for   
gene-silencing applications can be controlled by manipulating their base-pairing thermodynamics [50]. 
Since the advent of the CuAAC, modifying the positions typically chosen on the heterocycles of 
natural nucleobases has been significantly streamlined. The most common accessible sites for chemical 
alteration on the purine heterocycles include, but are not limited to the 7-aza or deaza and the   
N
9-positions of both adenine and guanine, the 6-N exocyclic amine of guanine and the 2-N exocyclic 
amine of adenine. Regarding the pyrimidine heterocycles, positions C5, the 4-N exocyclic amine of 
cytosine and the N
1-positions are most notable for chemical modification. Aside from modifying the 
natural nucleobases themselves, triazoles have been introduced as 1′-furanose sugar-base tethers [51], 
or used for the production of synthetic nucleobase analogues as mentioned earlier. In contrast, many 
nucleobase modifications have been positioned at the C5 position for pyrimidines, and the 7-deaza 
position for purines to avoid the Watson-Crick base-pairing region and occupy space within the major 
groove of the DNA/RNA duplex. This strategy provides an avenue through which to click-conjugate 
large molecules for the purposes of delivery, fluorescent visualization, and for duplex conformational 
studies [37,52,53]. In addition to these functions, these base analogues also form the basis of potential 
antiviral and anticancer agents [54,55]. Current examples of antiviral nucleic acid-based derivatives 
which inspire the continued implementation of the CuAAC in developing prospective therapies include 
the discovery of ribavirin [25,56], a successful 1,2,4-triazole-based antiviral nucleoside analogue, and 
the potent anti-HIV agent known as AZT (3′-azido-3′-deoxythymidine) [57]. 
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2.1.1. ASOs and siRNAs 
ASOs are single-stranded DNA (ssDNA) molecules that target and hybridize through Watson-Crick 
complimentarity to specific messenger RNA (mRNA) transcripts in cells in order to down-regulate the 
expression of problematic proteins [58–60]. Upon binding to the target RNA sequence, the ASO:RNA 
duplex either recruits RNase H which actively cleaves the RNA transcript, or physically inhibits its 
proper translation. In order to evaluate the efficacy of ASO-based constructs, there is much focus on 
increasing the thermostability of DNA:RNA interactions, while increasing the ASO’s resistance to 
enzymatic degradation [61]. In an effort to enhance this DNA:RNA duplex thermostability, Nielsen 
and colleagues chose to incorporate hydrophobic and aromatic moieties at the C5-position of 
pyrimidines through a triazole tether [62]. This and other studies have shown that incorporation of 
hydrophobic groups within the major groove can increase the stability of duplex oligonucleotides 
through stacking interactions [41,63–65]. Triazoles themselves are well suited for increasing duplex 
stability because they can stack favorably [66,67] and can potentially form H-bonds with the   
C5-proton [62]. 
The C5-iodo cytidine 1 [68] (Scheme 1) building block underwent a Sonogashira cross-coupling 
with trimethylsilane (TMS)-acetylene, which was subsequently click-cyclized with phenyl-azide to 
produce cytidine analogue 2 in 80% yield. After taking the appropriate steps to achieve the 
corresponding phosphoramidite building block 3, several DNA sequences were synthesized containing 
the cytidine analogue, along with others containing the corresponding 5-(phenyltriazole)uridine [66] 
nucleoside. After comparing the thermostabilities of the various duplexes containing the   
5-(phenyltriazole)pyrimidines, it was discovered that the uridine analogue was more well tolerated 
when complimented with RNA or with duplex DNA as a triplex-forming oligonucleotide (TFO). In a 
similar study, DNA molecules containing 5-triazole-benzenesulfonamide-modified pyrimidines such 
as compound 4 (Figure 1) in the central region were also found to strongly hybridize to RNA [65]. In 
both studies, it was observed that duplex stability increased with incremental additions of consecutive 
C5-triazole-modified pyrimidines in the oligomer as a result of enhanced stacking interactions. 
2.1.2. Oligonucleotide Based Nano-Materials 
Finding a facile method of synthesizing new materials is of great interest to material chemists. The 
CuAAC offers an ideal synthetic strategy towards the development of material libraries used for 
various downstream applications. Some applications of triazole-based DNA nano-materials that have 
been explored by members of Seela’s group include click-conjugation for drug delivery [41] and the 
development of DNA nanopatterns on a solid support [73]. Based on the pyrazolo[3,4-d]pyrimidine [74] 
scaffold instead of a purine, they functionalized the 7-deaza position of the 2′-deoxyguanosine 
analogue with alkyl linkers of varying length containing terminal mono- or di-acetylenes (compounds 
6 or 7; Figure 2) [41]. After incorporating the 8-aza-7-deaza-7-(octa-1,7-diynyl)-modified  
2′-deoxyguanosine (dG) analogue nucleoside phosphoramidite 6 at the 5′ end or within the central 
region of synthetic oligonucleotides (6a, Scheme 2), the modified oligonucleotides were click-ligated 
to azide-functionalized silicon wafers 6b [73]. 
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Scheme 1. Synthesis of C5-triazolo modified pyrimidines with aromatic substituents for 
increased duplex stability. 
 
Figure 1. Example compounds used for ASO and siRNA-based applications. 
 
SiRNAs are double-stranded RNA molecules approximately 21 base pairs (bp) in length, whereby 
the active RNA strand (guide) utilizes an endogenous pathway to selectively target and cleave mRNA 
transcripts [18]. In addition to enhancing their target specificity or decreasing their susceptibility to 
enzymatic degradation [9,69], siRNAs are often chemically modified to reduce their binding to 
proteins which are not part of the RNA interference (RNAi) pathway [70]. Proteins containing motifs 
which bind to double-stranded RNAs in a sequence-dependent manner interact with these duplexes 
primarily through their minor groove [71,72]. Based on this knowledge, a minor-groove modification Molecules 2012, 17  12670 
 
on the RNA duplex was performed by Beal and colleagues in which a 2-N-(methyltriazolyl) 
ethylpiperidine purine analogue 5 (Figure 1) was substituted into both the non-active passenger and 
guide strands to influence the protein-binding properties of these RNAs [47]. Not only did the resultant 
RNAs modified with this compound retain their gene-silencing activity, but those that were modified 
in the non-active passenger strand exhibited reduced binding to the adenine deaminase ADAR1 
(adenine deaminase that acts on RNA-1). 
Scheme 2. DNA strands containing 7-deaza-monoacetylenes “clicked” on to surface of 
azide-functionalized silicon wafers. 
 
The immobilized oligonucleotides formed self-assembly patterns due to the position of the dG 
analogue and compounded intra- and intermolecular forces such as phosphodiester-nucleobase 
interactions, base [75] and triazole [66] stacking interactions, and the hydrophobicity of the alkyl 
linkages. Seela and colleagues continued to functionalize compound 7 (Figure 2) through the   
double-click cycloaddition of various azides such as benzyl-N3, PEG-N3, AZT, and a C11-N3 alcohol 
for the purposes of drug delivery (8, Figure 2) [41]. 
Figure 2. Structures of 8-aza-7-deazaguanosine analogues with 7-deaza-mono- or   
di-acetylenes for further click conjugation. 
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2.1.3. Structural Determination 
Many functional groups are being used as potential molecular labels for further elucidating the 
structures and functions of DNA and RNA-based compounds. Rather than site-specifically 
incorporating a pre-functionalized nucleoside into synthetic oligonucleotides, Helm and colleagues 
developed a coumarin chromophore-based post-synthetic RNA alkylating agent 9 they labeled as 
N3BC (Scheme 3) [76]. 
Scheme 3. Site-specific N
3-alkylations of uridine residues with the coumarin-based 
compound N3BC. 
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N3BC, which was synthesized in five steps starting from 3-aminophenol for an overall yield of 
44%, was found to be specific for alkylating the N
3-position of uridines (10, Scheme 3) once exposed 
to the target RNA sequence and has a coumarin-based excitation wavelength of 320 nm. Alternatively, 
the N3BC-modified RNAs could undergo conjugation with alkyne-functionalized fluorophores or 
other ligands due to the free azide moiety. An alternative method of post-synthetically modifying the 
central region of native RNA molecules was developed by Sasaki and colleagues in which a 
functionality-transfer reaction (FTR) takes place between the DNA-based probe carrying the desired 
modification and the complimentary RNA sequence destined for modification (Scheme 4) [77]. After 
incorporating C6-thioguanosine into the synthetic DNA probe, the C6-thio is targeted for alkylation 
with the 2-methyliden-1,3-diketone transfer group. After the probe hybridizes with the complimentary 
target RNA sequence, the FTR selectively proceeds to modify the C2-amino group of the native 
guanine base opposite from the functionalized C6-thioguanosine (11, Scheme 4). The FTR-modified 
RNA molecule containing a terminal alkyne from the transfer group could undergo further   
click-mediated ligation with various azide compounds (12, Scheme 4). The initial results from these 
click ligations showed nearly quantitative yields with all compounds tested [77]. 
To examine the folded structures and conformation of DNA or RNA oligomers within biological 
environments, electron paramagnetic resonance (EPR) [78] coupled with site-specific spin-labeling of 
the oligomers has become a useful tool. In preparation for use of this technology, the Seela group used 
click chemistry to modify DNA and RNA molecules containing alkyne-functionalized purine and 
pyrimidine analogues 13 and 14 (Figure 3) with the radical azide nitroxide 4-azido-2,2,6,6,-
tetramethylpiperidine 1-oxyl (4-azido-TEMPO) [79] spin-label (Scheme 5) [52]. This was the first 
example of click-modifying oligonucleotides at the site of the nucleobase with spin-labels for 
subsequent EPR analysis. Molecules 2012, 17  12672 
 
Scheme 4. Template-driven central modifications of target RNA sequences through a 
functionality-transfer reaction (FTR). 
 
Scheme 5. The post-synthetic click-ligation of the 4-azido-TEMPO spin label to   
alkyne-functionalized oligonucleotides. 
 
Positron emission tomography (PET) is another molecular imaging technique which can track the 
distribution and behavior of radiolabeled bioactive molecules in vivo [80]. Most PET scanning 
procedures involve the use of 
18F-radiolabeling due to its short half-life and covalent stability [81]. The 
1,3-dipolar click cycloaddition has also been employed as a quick and efficient method of attaching 
nucleobase mimics to the 1′-position of the furanose ring. Utilizing this efficient strategy to modify 
nucleoside furanose rings, compound 15 (Figure 3) containing the 
18F-radiolabel was synthesized, 
starting with the 1′-β-ethynyl-2′-deoxyribonucleoside building block and its terminal incorporation into 
synthetic oligonucleotides via phosphoramidite chemistry [82]. The meta- or para-radiolabeled   
1-azido-4-([
18F]fluoromethyl)benzene prosthetic group was then post-synthetically click-conjugated to 
the 1′-ethynyl building block within the modified oligonucleotide. 
Figure 3. Structures of purine, pyrimidine or nucleobase mimics containing   
triazole-tethered spin-labels. 
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2.1.4. Fluorescent Labeling 
Attaching fluorescent labels to nucleobases [35,37,53] or making the bases an integral part of the 
fluorophore [36,46,83] is a highly sought after practice for the labeling of oligonucleotides. Since 
fluorescent nucleobases in DNA and RNA oligonucleotides hybridize directly to the target 
oligonucleotide or protein, they can provide visual representations of oligo-target hybridization 
properties as probing tools [35] or can gather information to form structure-activity relationships [76]. 
The ease of attaching either fluorescent or fluorescence-promoting compounds to nucleobases via the 
CuAAC has resulted in numerous reports in this field. It is also worth noting that fluorescence can be 
triggered once a triazole moiety is appended to certain nucleobases, such as adenosine at the C8 
position [84,85]. 
Although we have already discussed other uses for C5-triazole-modified pyrimidines, the following 
report describes the synthesis of the fluorescent C5-triazolylcytidine nucleoside analogue 20 (Figure 4). 
This cytidine analogue was the first example of a C5-ethynylcytidine building block being   
click-cyclized with an azide residue to form a fluorophore, without the attachment of an actual 
fluorophore to the molecule [36]. As previously outlined, a motivation for modifying the C5 position 
of pyrimidines is that these modifications are well accommodated within the major groove of duplex 
oligonucleotides, thus leaving the overall natural conformation of the duplex unperturbed. In the   
same year, a similar study click-conjugated the fluorophore Nile Red at the C5-position of uridine to 
yield compound 21 (Figure 4) [53]. The difference with the synthetic scheme presented in the   
latter study was that the C5-iodopyrimidine was first incorporated into oligonucleotides, followed   
by a post-synthetic azide displacement at the C5 with NaN3 and the click-attachment of the   
alkyne-functionalized dye. Using fluorescence to detect the presence of single-nucleotide 
polymorphisms (SNPs) in target DNA or RNA sequences, Hrdlicka and colleagues used the CuAAC 
to attach a pyrene residue at the C5 position of uridine through a triazole moiety [35]. Compound 22 
(Figure 4) showed favorable mismatch discrimination by significantly decreasing its quantum yield in 
the presence of mismatched sequences. 
The expansion of the pyrene′s application as a fluorescent compound is made evident when   
1-azidomethyl pyrene is “double-clicked” with the reaction substrate 7-tripropargylamine-7-deaza-2′-
deoxyguanosine containing two terminal acetylenes (Scheme 6) [37]. These labeled guanosine 
analogues differed slightly from the 8-aza variant of the compound 7 previously mentioned by the 
Seela group (Figure 2). The starting material 7-iodo-7-deaza-2′-deoxyguanosine 16 [86] (Scheme 6) 
underwent the Sonogashira cross-coupling reaction with a ten-fold excess of tripropargylamine, 
producing the aforementioned di-acetylene 17 on the 7-deaza position. After transforming the   
di-acetylene into the appropriate phosphoramidite 18, this compound was used to site-specifically 
incorporate the bis-pyrene modification at various positions within 12-mers of ss- and dsDNA as a dG 
substitution. The melting temperatures (Tms) of all di-acetylene-modified oligomers were slightly 
increased above the reference value (50 °C) ranging from 50–56 °C, indicating that the larger 
tripropargylamine linkages did not disturb the native duplex structure. After double-clicking the   
1-azidomethyl pyrene residues to the di-acetylenes (19, Scheme 6) and in addition to the noticeable 
increase in duplex Tms, excimer fluorescence [87] was achieved between bis-pyrene-modified purines 
when placed on opposite strands of the duplex and separated by two base pairs. Molecules 2012, 17  12674 
 
Scheme 6. Synthesis and oligonucleotide incorporation of double-click conjugated   
bis-pyrene 2′-deoxyguanosine analogues. 
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Seela and colleagues have adopted the CuAAC as the single-most useful tool for performing facile 
transformations on nucleosides to produce novel building blocks which find use in a variety of 
applications. Although not related to fluorescent labeling, this report by Seela’s group synthesized the 
triazole-modified compound 24, to be a mimic of the G-clamp [88] (Figure 4). The G-clamp 23 is a 
nucleoside analogue which is known to provide greater stability to 2′-deoxyribocytidine:guanidine 
(dC:dG) interactions when substituting dC residues [89]. Their goal was to fortify the duplex stability 
within parallel-stranded DNA (psDNA) through this alternative G-clamp mimic, in order to explore 
the possibilities presented by psDNA as a future biomimetic for biological applications. Adopting the 
design of this G-clamp mimic 24 which uses the pyrrolo-dC [83] scaffold 25 and its native fluorescence 
capabilities, Seela’s group synthesized an alternative triazole-modified pyrrolo-dC derivative 26, 
displaying a quantum yield ten times greater than the reference design [32]. In contrast to the results 
presented by Hrdlicka and colleagues regarding the uridine analogue 22 with a C5-triazolo-pyrene and 
its mode of action for detecting mismatches [35], compound 26 experiences severe quenching of 
fluorescence when hybridized to matching sequences and an increase in quantum yield as mismatches 
occur. Since derivative 26 represents a substitution for dC, the compound′s fluorescence is most 
severely quenched when opposite a dG residue on the target sequence. The quantum yield slowly 
increases in the following order depending on the opposing residue: dG < dT < dA < dC. 
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Figure 4. Triazole-modified nucleic acid-based compounds with fluorescent properties 
which also serve as precursors for other applications. 
 
2.1.5. Anticancer and Antiviral Development 
The discovery of antiviral agents such as AZT and Ribavirin have inspired chemists to investigate 
the use of the CuAAC to develop libraries of potential antiviral and anticancer therapeutics [90]. With 
the knowledge that azides and alkynes are selectively reactive with each other, are inert moieties when 
exposed to biological conditions, and cyclize to produce a stable 1,4-disubstituted isomer of the   
1,2,3-triazole, the CuAAC has shown great versatility in producing numerous nucleic acid-based 
derivatives which target molecules implicated in the propagation of viral disease and cancer [1,3,4,8]. 
Mono-nucleoside compounds which have proven themselves to be useful anti-pathogenic agents are 
acyclic nucleoside phosphonates (ANPs) [91]. In place of the typical furanose ring found in native Molecules 2012, 17  12676 
 
nucleotides is an acyclic alkyl chain connecting a phosphonate moiety to the N
1-position of pyrimidines 
or the N
9-position of purines. Some examples of click-modified ANPs are compounds 33 [22] and 34 [92] 
(Figure 5) which showed potential against the Hepatitis C Virus (HCV) [22] or as a future antiviral 
agent [92]. An N
1-acyclic pyrimidine modification which did not include a phosphonate moiety is 
compound 35, designed for its intended use as an antivirulent and showing promising preliminary 
results as an antioxidant [93]. 
Figure 5. Nucleic acid-based compounds displaying anticancer or antiviral properties. 
 
Compounds such as 5′-fluorouracil (5′-FU) [94], floxuridine, gemcitabine and clofarabine are 
examples of known fluoronucleoside-based anticancer compounds. The effectiveness of these 
compounds is in some cases the driving force behind the rapid click-mediated production of 
fluorinated compound libraries with anticancer potential [54]. Using the same synthetic strategy to 
modify the C5 position of 2′-deoxypyrimidines [36,62], all C5-modified pyrimidine analogues 
containing a perfluorodecyl-substituted triazole unit such as derivative 36 showed inhibition of cancer 
cell growth [54]. Agrofoglio and colleagues also made a contribution after designing a library of  
C5-substituted click adducts upon discovering that compound 37 not only inhibited a variety of   
DNA-based viruses, but also displayed anti-tumor activity which was comparable to the reference 
compound 5′-FU [55]. 
Lakshman and coworkers modified the O
6-position of inosine with an azide group, in order to  
form a click attachment point for several alkyne-modified functionalities such as 4-ethynyltoluene 
(Scheme 7) [95]. Molecules 2012, 17  12677 
 
Scheme 7. Synthetic strategy to isolate the C6-azido purine tautomer for click-cyclization 
with various alkynes. 
 
After the azide displacement reaction with the protected O
6-(benzotriazol-1-yl) intermediate 27, the 
azide 28 would equilibrate with its N
1-tetrazolyl tautomer 29. Until solvent conditions were optimized 
to isolate the azido tautomer as the major reactant, the CuAAC conjugation of alkyne-based 
functionalities was low-yielding or did not occur. Realizing that formation of the tetrazolyl tautomer 
was a potential hindrance to the CuAAC, Mathew et al. decided to use a C6-chloro-protected purine as 
the substrate for the Sonogashira cross-coupling reaction with TMS-acetylene to introduce a   
C6-acetylene (30, Scheme 8) [96]. The result of this alternative synthetic strategy coupled with the 
CuAAC lead to the discovery of several different triazole-modified derivatives such as the   
homo-purine dimer compound 31. Both articles focused on the development of agonists or antagonists 
for adenosine receptors, since they are expressed in almost every cell and therefore present a popular 
target for potential drugs [96]. 
Scheme 8. Synthesis of triazole-linked di-nucleosides to be used as anti-adenosine receptor ligands. 
 
Referring back to triazole-based substitutions at the 1′-furanose position, there are a few examples 
of bioactive mimics containing functionalities attached through a five-membered ring systems at this 
site [97]. Capitalizing on this trend, the following Fmoc-protected 4-(aminomethyl)-1,2,3-triazolyl Molecules 2012, 17  12678 
 
nucleoside analogue 38 (Figure 5) was synthesized for its potential use as an antiviral agent [98].  
A more recent example of a 1′-triazole-modified nucleoside analogue which could have antiviral 
effects is compound 39, containing a 4-(triazolyl)-p-methoxyphenyl substituent which successfully 
inhibited an E. coli nicotinamide adenine dinucleotide malic enzyme (NAD ME) [99]. An expedient 
method of implementing the click-modification of a nucleoside mimic at the 1′-furanose position was 
developed with the assistance of ultrasonic irradiation [97]. With the help of an Fe(III) catalyst (FeCl3), 
this one-pot synthetic strategy to click-modify a 1′-azidofuranose building block using ultrasonic 
irradiation reduced reaction times from hours to minutes while increasing the overall yield (Scheme 9).  
Scheme 9. One-pot synthesis of C1′-triazolo nucleobase mimics with ultrasonic irradiation. 
 
In addition, the active compound 32 significantly reduced the viability of chronic myelogenous 
leukemia (CML) K562 cells by 93%, compared with a known CML inhibitor AICAR which lowered 
cell viability by 35%. Itzstein and colleagues further extended the click-based modification at the  
1′-sugar position by adding a methylene bridge at the sugar-triazole junction [100]. The resultant   
1′-homo-N-nucleoside derivative 40 (Figure 5) will be tested for its application as an antivirulent. 
Another group used a unique TBS-directed CuAAC method to force the production of the   
1,5-disubstituted regioisomer of the more common 1,4-1,2,3-triazole [33]. Their inspiration came from 
examples of fluorinated and highly-bioactive molecules containing 1,5-1,2,3-triazoles [101]. The 
antiviral and cytotoxic evaluation of compound 41 with its 5-trifluoromethyl substituted 1,2,3-triazole 
in the 1′-furanose position is underway. 
2.2. Sugar Modifications 
Modifications at the sugar moiety of nucleosides are commonly employed for the purpose of 
developing novel anti-viral or cancer therapeutics and for applications which would benefit from 
appending useful molecules to mono- or oligonucleotides. Applications of nucleoside analogues with 
modified sugars are generally the same as for analogues with modified bases and backbone structures. 
However, the sugar moiety is restricted to a small number of modifiable sites. The positions which are 
modified on the sugar are typically C1′ to C5′ (or C6′ for locked nucleic acids (LNA) [102]) [48]. For 
the purposes of this review, we will be focusing on the sugar positions C2′, C3′ and C5′. Nucleoside 
analogues where modifications are performed on the C3′ or C5′ positions are either meant to be used as 
monomer or dimer units, or occupy the terminal ends of DNA or RNA oligonucleotides [57,103–107]. 
The C2′ position offers the opportunity to place modified nucleoside analogues throughout chemically 
synthesized oligonucleotides since elongation usually occurs from the C3′ or C5′ positions [48,108–110]. 
The CuAAC has found utility in attaching molecules to these positions through a triazole tether, Molecules 2012, 17  12679 
 
especially since AZT is a readily available starting material containing a C3′-azido group [57]. Using 
common procedures to functionalize these sugar positions with either azides or alkynes, the CuAAC 
has become a great tool in churning out libraries of potentially useful nucleic acid-based compounds. 
2.2.1. C3′-Modified Sugars 
Many researchers utilize the CuAAC with AZT as the precursor thymine analogue in order to 
functionalize the C3′ using a variety of alkynes for various applications. For C3′-triazolo-modified 
compounds synthesized from AZT as the precursor, refer to Figure 6. The goal for the first two 
structures which were derivatized from AZT was to act as inhibitors of 2′-deoxynucleoside kinases 
(dNKs) such as thymidine kinases in particular. Thymidine kinase 1 (TK1) was the target of compound 
42 (Figure 6), among several compounds synthesized from AZT by Erikkson and colleagues [57]. TK1 
is responsible for the rate-limiting step of initiating DNA replication [111] and is over-expressed in 
malignant cell lines [112], thus making it a suitable target for synthetic ligands. Van Calenbergh and 
colleagues synthesized nucleoside analogues with an additional C5-(2-bromovinyl) group on the 
nucleobase [103]. An example is compound 43 which was selective for thymidine kinase 2 (TK2), a 
dNK which is responsible for phosphorylating dNTPs for mitochondrial DNA replication [113]. Their 
goal was to understand the mechanism through which nucleic acid-based antiviral or anticancer 
therapies cause mitochondrial DNA toxicity. Compound 44 was synthesized to serve as an anticancer 
agent and as an optional fluorescent tag at the 3′-ends of oligonucleotides due to the quinine 
substituent [105]. With the intention of producing inhibitors for the popular drug target HIV-1 RT,  
Roy et al. modified AZT with both 1,4- and 1,5-disubstituted isomers of the azide-functionalized 
1,2,3-triazole 45 based on AZT′s success at inhibiting the same enzyme [107]. 
Figure 6. Various C3′-triazole modified 2′-deoxyfuranoses. 
 
2.2.2. C5′-Modified Sugars 
Ribose sugars with C5′ azide or alkyne groups can be introduced at the 5′-ends of synthetic 
oligonucleotides and along with many other applications, they can be further click-functionalized with 
molecules to improve delivery [106] or to enhance their specificity and potency as cytotoxic agents [104]. Molecules 2012, 17  12680 
 
In the pursuit of therapeutic design, Wu and colleagues explored a series of C5′-triazolo modified 
uridines, thymidines and cytidines to screen for anticancer properties [104]. Compound 46 (Figure 7) 
showed substantial cytotoxic profiles against three of the four cancer cells lines tested, surpassing the 
reference compound 5′-FU with a six-fold increase in potency. With an interest in gene-silencing 
therapies, Manoharan and colleagues attached long-chain fatty acids to alkyne-functionalized sugars 
throughout synthetic siRNAs. They discovered that siRNAs containing compound 47 at the 5′ end of 
the sense strand displayed enhanced activity compared to all other modified constructs, including the 
wild-type duplex [106]. 
Figure 7. Uridine nucleoside analogues C5′-triazole modified sugars. 
 
2.2.3. C2′-Modified Sugars 
The last optional position to modify at the furanose sugar moiety in nucleic acid residues   
while remaining within the scope of this review is the C2′ position. Unlike the C3′ and C5′ positions, 
nucleic acids containing C2′ sugar modifications can still be incorporated throughout synthetic 
oligonucleotides since this position does not typically participate in strand elongation. Towards the 
development of C2′ modified nucleoside monomers, Liebscher and colleagues devised a method of 
click-appending cholesterol molecules with variable-length aliphatic linkers to the C2′ position of 
uridine [109]. Using various solid-state and 2D-NMR spectroscopic techniques, this group verified  
that compound 49 (Figure 8) containing a cholesterol group tethered to the C2′ sugar position   
through a triazole moiety could anchor to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
membranes. Capitalizing on the successful design of double-headed nucleosides for potential 
therapeutic applications or for DNA and RNA structural studies [114], another group extended the 
design by attaching nucleobases to various positions of the sugar moiety, particularly the C2′ position [48]. 
Incorporating compounds 50 into duplex DNA or RNA molecules, Nielsen and colleagues studied the 
effects of these double-headed derivatives on nucleic acid secondary structures. 
Based on their previous work with 2′-azido modified 2′-deoxyuridine/adenosine analogues which 
were compatible with siRNA constructs [115], Fauster et al. extended the work by producing cytidine 
and guanosine 2′-azido modified analogues [108]. The synthetic assembly of oligonucleotides using 
phosphoramidite chemistry has generally proven incompatible with azides. In the presence of P(III), 
azides have proven to be highly susceptible to the Staudinger reduction [116]. It is for this reason that 
most groups who wish to click-derivatize their oligonucleotides, tend to append alkyne groups to their Molecules 2012, 17  12681 
 
oligomers in preparation for cyclizing with azide-functionalized molecules. Despite these findings, 
Fauster  et al. went ahead to prove that azide functional groups at the furanose C2′-position are 
compatible with the steps of automated oligonucleotide synthesis (Scheme 10) [108]. 
Scheme 10. RNA synthesis using phosphoramidite chemistry in the presence of free azide 
moieties and their compatibility with the chemistry. 
 
Phosphoramidites 48 were site-specifically incorporated into the growing oligonucleotide to place the 
C2′ azide in the desired position(s), using 1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole (MSNT) [117] 
as an activator. Automated addition of remaining residues continued without affecting the free azide 
moieties on the oligomer. The resulting azido-siRNAs were then post-synthetically labelled with the 
fluorophore F545 through the CuAAC. Even though pyrene is commonly used as a fluorescent label 
due to its innate character as a fluorophore [118], this next group used this aromatic functionality to 
produce non-discriminatory DNA and RNA probes [110]. These universal probes can be useful when 
the target sequence contains a couple of unknown residues. In the presence of mismatched sequences 
or abasic sites, compound 51 (Figure 8) was least discriminating as determined by the minimal 
perturbations in probe:target duplex Tms. The tentative explanation for this behavior is that the pyrene 
substituent is intercalating into the duplex core and pushing out the opposing nucleobase, thus allowing 
for universal hybridization devoid of a Watson-Crick interaction. 
Figure 8. Structures of C2′-triazole modified nucleosides. 
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2.3. Backbone Modifications 
The goals which stem from modifying all three key areas of nucleic acids are relatively the same, in 
that all studies pursue the advancement of both structural and functional characteristics of nucleic  
acid-based derivatives. In order to retain or to enhance properties which are favorable for ASO and 
siRNA-based constructs, modifications at the site of the backbone are also of great interest. Examples 
of areas which would benefit from backbone-targeted modifications include the production of   
longer or multi-branched oligonucleotides and synthetic genes. Currently, there is an upper limit of 
approximately 100 bases in the length of DNA by using traditional DNA and RNA synthesis 
techniques such as solid-phase phosphoramidite chemistry [119]. To overcome this size limitation, a 
new class of backbone-modified oligonucleotides that utilize the 1,4-disubstituted 1,2,3-triazole as the 
internucleotide linkage has emerged in the last decade [26,120]. Another attractive feature in utilizing 
triazole-linked oligonucleotides is the enhanced resistance towards endo- and exonuclease-mediated 
cleavage, which improves construct bioavailability within physiological environments [2,8,19]. 
2.3.1. DNA Backbone Modification 
In one study by Chandrasekhar et al., a triazole linked 2′-deoxythymidine nucleoside phosphoramidite 
59 (Figure 9) was synthesized for its direct use in solid-phase oligonucleotide synthesis [121]. This 
dimer unit can be placed at any requisite site in the chain. They designed a new dinucleoside 
phosphoramidite with the sugar part of the nucleotide unaltered. The monomer unit 55 (Scheme 11) 
containing the terminal acetylene moiety which serves as the precursor for the prospective   
triazole-linked dimer was synthesized from commercially available thymidine 52 in five steps. 
Succeeding the protection of free alcohols, the group then selectively deprotected the 5′-OH with  
10-camphorsulfonic acid [122], yielding derivative 53. The free alcohol was then oxidized with   
Dess-Martin periodinane, subjected to the Corey-Fuchs protocol [123] and then treated with 
ethylmagnesium bromide (54, Scheme 11). The two key fragments which were the azide unit (AZT) 
and the terminal acetylene 55 were then clicked together through the CuAAC reaction to yield the 
target triazole-linked dimer phosphoramidite 59 (Figure 9). 
Scheme 11. Synthesis of the thymidine 4′-alkynylated monomer. 
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Sequentially heterogeneous oligonucleotides bearing a similar triazole-linked dimer 60 (Figure 9) 
was synthesized by the Florentiev group [124]. Their triazole-based linker was one atom longer than 
Chandrasekhar’s modification. Similarly, their synthetic strategy also included the use of Dess-Martin 
periodinane in order to oxidize the 5′-OH to an aldehyde, after which the dibromoalkene was 
synthesized as an intermediate to convert the aldehyde into a terminal alkyne. The CuAAC reaction was 
then carried out between the terminal alkyne and 3′-azido-3′-deoxy-5′-O-dimethoxytritylthymidine. 
After assessing the effects of single and multiple modifications on the thermostability of mixed-base 
duplexes, an average drop in Tm of −4 °C was observed indicating that the incorporation of this triazole 
linked dimer was slightly destabilizing for its hybridization ability. 
A click-ligated DNA strand 58 (Scheme 12) made up of 81 residues has been synthesized between 
oligonucleotides containing 3′-AZT 56 and 5′-propargylamido-2′-deoxythymidine 57 residues [125]. 
In order to more efficiently assemble the oligonucleotides with 3′-AZT and avoid the potential 
incompatibility of the azide group with P(III) chemistry [116], the required sequences were assembled 
in the 5′ to 3′ direction using 3′-DMT-5′-phosphoramidites of DNA nucleotides. To produce the   
azide-functionalized DNA strand, AZT was added as a phosphotriester monomer to the 3′-end of the 
designer strand after its automated assembly had terminated. The alkyne-modified oligonucleotides to 
serve as partners for the 3′-AZT strands were assembled through the 5′-ended solid-phase coupling of 
the 5′-propargylamido thymidine analogue (57) phosphoramidite, which was synthesized from the 
carboxylic acid derivative of thymidine [126,127]. The resultant click-ligated DNA strand displayed 
compatibility with various polymerases as a PCR template and at the time, served as the first example 
of a novel DNA ligation which could undergo reproducible PCR amplification. 
Scheme 12. Synthesis and PCR amplification of an unnatural triazole-based DNA backbone. 
 
Brown and colleagues not only explained the biocompatibility of the triazole linkage within 
synthetic oligonucleotides [128], but also examined the structure and base-pair dynamics of a DNA 
duplex containing a single triazole linkage between two central thymidine residues (61, Figure 9) using 
NMR solution techniques [129]. The triazole-modified DNA duplex was found to share structural 
similarity with the reference B-form helical conformation. Although a slight disturbance in the Molecules 2012, 17  12684 
 
thermodynamic profile of the modified duplex is observed, the triazole linkage 61 promises 
biocompatibility with polymerases or other such biomolecules. 
Figure 9. DNA oligonucleotides containing triazole-based internucleotide linkages. 
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2.3.2. RNA Backbone Modifications 
In addition to triazole-modified backbones in DNA molecules, a number of RNA analogues have 
been synthesized using click chemistry, in which the native phosphodiester linkages are replaced by 
triazoles. Examples of such analogues were demonstrated by El-Sagheer and Brown through the   
click-ligation of smaller azide and alkyne functionalized ribo- and deoxyribonucleotide polymers, into 
a series of catalytically active RNA and DNA:RNA chimeric hairpin and hammerhead ribozymes of 
approximately 100 nucleotides in length [26]. After synthetically assembling and derivatizing 
individual oligonucleotides with either azide or alkyne functional groups, they are click-cyclized to 
produce larger molecules. In order to produce these RNA or DNA:RNA hydrids (64, Scheme 13), 
click-ligation occurred between terminal azides or acetylenes placed on either 3′ or 5′ ends of 
individual DNA or RNA strands, as displayed on the 5′-azido modified uridine and 3′-propargylated-
2′-deoxycytidine analogues (62, 63). Both modified hairpin and hammerhead ribozymes were shown 
to cleave their substrates, thus indicating the potential compatibility of these triazole-based backbone 
linkages with many biologically important DNA or RNA molecules.  
Scheme 13. Click-mediated synthesis of the DNA-RNA hydrids. 
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Paredes and Das extended this work by enzymatically incorporating “clickable” azido groups onto 
5′ and 3′ terminal ends of an RNA oligonucleotides via novel azide-labeled nucleotide triphosphates 
(NTPs) [120]. Once the clickable groups were installed on individual RNA strands, rapid click radiolabeling 
could ensue, or template/non-template driven RNA-RNA click ligations were then possible. Linkage 
65 (Figure 10) is the result of a successful template-driven RNA-RNA click ligation using fragments 
of the hepatitis delta virus (HDV) ribozyme. The rate and the extent of target cleavage displayed by the 
triazole-modified HDV ribozyme was indistinguishable from the transcribed wild-type HDV ribozyme, 
again indicating a broad applicability of click chemistry in RNA-comprised biological systems.  
Figure 10. Structures of nucleoside analogues linked through a triazole moiety.  
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In 2011, Rozners and colleagues synthesized a uracil-adenosine phosphoramidite 66 (Figure 10) 
containing a triazole backbone unit [130]. The phosphoramidite approach allows the flexibility to 
incorporate the desired modification in a site-specific manner throughout the growing oligonucleotide 
construct. The key consideration in their design was minimizing the synthetic effort and their approach 
involved the coupling of a 3′-O-propargyl uracil monomer with a 5′-azidoadenosine monomer. 
Reporting a largely destabilizing effect on the RNA double helix (∆Tm −7 °C to −14 °C per modification 
in a 10 bp duplex), this group concluded that the triazole-based linkage was not an ideal replacement 
for the native phosphodiester linkage. In contrast to these findings and following their success with the 
solution-phase synthesis of unique triazole linked DNA (
TLDNA) 8-mer in 2008 [131], Isobe and 
colleagues extended their efforts towards the solid-support synthesis of a triazole-linked RNA 
analogue 67 on a solid support through the CuAAC [132]. Proton NMR analysis of these monomeric 
ribonucleoside analogues illustrates a preference for the C3′-endo puckering pattern found in natural 
ribonucleosides, which suggests a possible use for these triazole-linked nucleoside analogues within 
RNAi-based applications. With the intention of utilizing novel triazole linkages dispersed throughout 
duplex siRNAs, our lab reported the synthesis of a nucleoside dimer analogue 68 modified at the 
backbone with a triazole functionality [133,134]. These unnatural triazole-modified siRNAs were 
capable of silencing the exogenous reporter gene firefly luciferase, along with the endogenous gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in a dose-dependent manner. Incorporating 
these novel dimer analogues at the 3′-overhangs of siRNAs imparted an added resistance to nuclease-
mediated degradation when compared with unmodified duplexes. Despite the reduced thermostability Molecules 2012, 17  12686 
 
associated with these modifications, this study highlighted the first reported application of these novel 
triazole-based internucleotide linkages within functional siRNAs. 
2.3.3. Other Backbone Modifications 
The Winssinger group reported the substitution of an amide linkage in peptide nucleic acid (PNA), 
a successful oligonucleoside mimic made of repeating aminoethyl-glycine units [135], with a triazole 
linker [136]. PNA oligomers terminated with an azido monomer were prepared by standard   
Fmoc-based PNA synthesis [137], which were then cyclized with various alkyne monomers by means 
of the CuAAC reaction. The target PNA-based dimer 69 (Figure 11) with the triazole linkage had a 
negligible impact on the hybridization properties of modified PNA strands and sequence fidelity during 
PNA synthesis was maintained. These results indicate the suitability of a triazole in lieu of the amide 
linkage within PNA polymers and its capability with the click-templated coupling of PNA fragments. 
Krishna and Caruthers developed the 1,2,3-triazolylphosphonate (TP) internucleotide linkage 
wherein one of the non-bridging oxygen atoms of the phosphate linkage is replaced by a 1,2,3-triazole 
moiety, tethered via the C4 of the heterocycle [42]. This was the first time that click-mediated 
modification at the phosphorus center had been explored, with the exception of a triazole-
functionalization at the 5′-phosphate of a DNA strand [138]. The proposed 1,2,3-triazolylphosphonate 
internucleotide (TP) linkages (71, Figure 11) are generated through a two-step process. Initially the 
ethynylphosphonate internucleotide linkage 70 was introduced at designated sites through 
conventional phosphoramidite chemistry, followed with the post-synthetic CuAAC to introduce the 
appropriate azide before deprotection and cleavage of the oligonucleotide from the solid support. By 
coupling these two steps, chimeric oligonucleotides (16−23 mers) which contain up to six TP 
modifications as well as other functionalities such as LNA nucleotides, 2′-OMe ribonucleotides, and 
phosphorothioates [139] were synthesized. Nuclease stability assays indicated that these TP-modified 
ODNs were highly resistant towards exonucleases, whereas melting studies indicated a slight 
destabilization when a TP-modified ODN was hybridized to its complementary RNA. A fluorescently 
labeled 16-mer ODN modified with two TP linkages also showed efficient cellular uptake during 
passive transfection into mammalian cells. This methodology enables the multiple, high-density 
functionalization of the phosphorus-based backbone of an oligodeoxynucleotide using click chemistry. 
Various biologically relevant moieties, labeling dyes and diagnostic elements can be introduced at the 
phosphorus center as opposed to other typically modified areas of DNA nucleosides without 
compromising the product’s ability to hybridize to its compliment. 
2.4. Bio-conjugation 
Bioconjugation involves conjugating a particular biological scaffold to an existing oligonucleotide 
that can favorably alter its properties. For example, the poor cell or tissue-specific delivery of synthetic 
oligonucleotides can be addressed by attaching peptides, lipid derivatives, sugars and other small molecules 
to natural or modified oligonucleotides [140]. Fluorescent labeling of oligonucleotides enables us to 
detect, visualize and study the function of the synthetic oligonucleotides and their interactive behavior 
within biological systems [141]. Many dyes are incorporated post-synthetically, in which a small 
reactive group is introduced to a DNA or RNA oligonucleotide following deprotection [142]. The Molecules 2012, 17  12687 
 
CuAAC reaction has been successfully applied in bioconjugation reactions due to its reliability, 
efficiency, and the stability of alkynes and azides in most physiological and organic conditions. 
Figure 11. Synthesis of 1,2,3-triazolylphosphonate internucleotide (TP) linkages and the 
triazole-linked dimer within PNA. 
 
2.4.1. Nucleic Acids Delivery 
In order to enhance the uptake and stability of diagnostic and therapeutic oligonucleotides [143,144], 
Graham and Brown successfully attached a cell-penetrating peptide (Tat peptide) [145,146] to 
oligonucleotides via the CuAAC (Scheme 14) [147]. After attaching a click functional group to the 
target oligonucleotide, the Tat peptide was then functionalized with the opposing click-compatible 
group. To yield a 3′-azido-modified oligonucleotide (73), succinimidyl azidovalerate was synthesized 
and reacted with an amino-modified solid support. Propiolic acid was coupled to the N-terminus of the 
Tat peptide to form an amide bond which gave the necessary alkyne-modified peptide derivative 72. 
The two derivatives were then cyclized to form the resultant conjugated system 74.  
Scheme 14. Synthesis of oligonucleotide-Tat peptide conjugates. 
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Following the theme of forming peptide- and lipid-based bioconjugate systems, the conjugation of 
oligonucleotides to carbohydrates is also an effective way to improve the delivery and targeting 
capability of synthetic oligonucleotides. Kiviniemi and colleagues synthesized 4′-modifed  
alkyne-derivatized nucleosides which have been utilized in glycoconjuations (75, Figure 12) [148]. 
Azido-derivatized sugar ligands can be efficiently conjugated to the alkynyl groups of these nucleosides 
via click chemistry. The influence of the 4′-modifications on the melting temperature with DNA and 
2′-O-methyl RNA targets was studied. The mannose conjugation formed duplexes with complementary 
2′-OMe RNA, equivalent to the stability of those formed by the corresponding unmodified DNA. 
Figure 12. Various structures of triazole-linked oligonucleotide conjugates.  
 
Oligonucleotides are capable of self-aggregating into larger structures due to their sequence-
dependent complimentarity and their electronic properties. This next group utilized a technique 
referred to as atom transfer radical polymerization (ATRP) [149] coupled with click chemistry to Molecules 2012, 17  12689 
 
create controlled aggregates of DNA co-polymers [150]. They initiated the radical-induced   
self-assembly of alkyne-functionalized amphiphilic copolymers, followed by their click-conjugation to 
the 5′-end of alkynylated ssDNA molecules (76, Figure 12). Controlled radical polymerization (CRP) 
techniques such as ATRP can be attractive and facile alternatives to traditional methods of 
polymerization. Applying these techniques, Averick et al. succeeding in coating the core of a   
star-shaped copolymer comprised of azido groups on its extensions, with 3′- or 5′-alkynyl DNA   
strands through click-ligation (77) [151]. They extended the strategy to form click-conjugated   
DNA-copolymer hybrids which were concomitantly functionalized with other “clickable” residues 
containing fluorescent properties. Through these techniques, nucleic acid-based polymers of controlled 
size and arrangement can be rapidly produced and used for a variety of targeted applications. 
2.4.2. Copper-Free Click Ligation 
Despite the promising application of CuAAC reaction in oligonucleotide modification, the use of 
CuAAC in biological systems has been delayed by the fact that copper ions may damage DNA or 
RNA, thus yielding strand breaks [152]. However, there are several emerging studies that employ 
uncatalyzed versions of the cycloaddition reaction. The studies mentioned hitherto mainly focus on the 
use of cyclooctynes, which can undergo strain-promoted azide-alkyne cycloadditions (SPAAC) in the 
absence of a copper catalyst [153,154]. 
The conjugation of a ribonucleotide 16-mer with the cationic amphiphilic peptide penetratin and an 
anionic hyaluronan tetrasaccharide by means of Cu-free “click” chemistry was reported by the 
Filippov group [153]. The alkyne-functionalized 16-mer was prepared by automated solid-phase 
synthesis, using a newly developed strained cyclooctyne phosphoramidite 78 (Figure 13) in the final 
coupling. The cycloaddition reaction between these alkyne-functionalized RNA oligomers 79 and 
azide-containing biomolecules 80, was performed to generate the appropriate synthesized RNA 
conjugates 81. The SPAAC reaction was also explored by Manoharan and colleagues who similarly 
used strained cyclooctynes for Cu-free click cycloadditions to synthesize oligonucleotide-ligand 
conjugates such as derivative 82 [154]. Both groups demonstrated that an SPAAC reaction could be 
amenable to forming triazole-linked oligonucleotide-ligand conjugates within biological systems. 
Figure 13. Synthesis and the structure of RNA conjugates via the SPAAC reaction. 
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2.4.3. Oligonucleotide Labeling 
The azide-alkyne click cycloaddition has provided a means to functionalize oligonucleotides with 
fluorescent properties or to add compounds displaying those properties for clinical diagnosis and to 
analyze drug-target interactions [155,156]. Inkster and colleagues described the click-mediated 
attachment of a [
18F]FPy5yne prosthetic group [157] to a 5′-azide-modified ASO [158]. The 
 
18F-labeled oligonucleotide 86 (Figure 14) was obtained with a satisfactory radiochemical yield of  
24.6 ± 0.5% (decay corrected), which can then be used for in vivo PET imaging studies. Another 
example of post-synthetically attaching a fluorophore to oligonucleotides for PET imaging studies, the 
Luxen group are the first to directly label duplex siRNAs through the CuAAC (Scheme 15) [159]. The 
acetylene-based tether attached to a 3′-end of the duplex 83 served as a scaffold for attaching the azide-
functionalized [
18F]-radiolabelled derivative 84 through click chemistry, producing the conjugate 85. 
Figure 14. Examples of spin-labels and fluorescent residues linked to oligonucleotides 
through triazole tethers. 
 
Scheme 15. Synthesis of [
18F]-radiolabeled siRNA by using [
18F]fluoroazide. 
 
For Wagenknecht and colleagues, the CuAAC reaction fit the profile of being the most capable of 
bioorthogonal reactions required to post-synthetically label a target oligonucleotide with the Nile Blue 
chromophore [160]. The goal of the group was to study aspects of oligonucleotide structure [161,162] 
and the effects of chromophore stacking [163] using an acyclic linker scaffold. Incorporating an 
acyclic 2′-deoxyribonucleoside analogue in the form of a 3-amino-1,2-propanediol linker containing an 
alkyne tether into synthetic oligonucleotides was the first step towards setting up the click-bioconjugation. 
The azido-modified Nile Blue chromophore was subsequently click-cyclized with the free acetylenes 
and tethered through a triazole moiety to the resultant acyclic DNA-mimic scaffold (87, Figure 14). Molecules 2012, 17  12691 
 
2.4.4. Other Applications of “Click Conjugation” 
The use of DNA-directed chemistry is becoming increasing popular due its capability of positioning 
reactants for subsequent reactivity with accuracy and specificity [164]. Since triplex-forming 
oligonucleotides (TFOs) have been shown to provide an adequate scaffold for controlling specific 
chemical transformations [165], small molecules employed as TFO binders can be used to influence 
these TFO-mediated chemical transformations. In an attempt to modulate a di-click conjugation 
towards the formation of a TFO, a dialkyne-DNA construct and two azido-functionalized DNA   
strands were covalently paired through a triplex DNA binder [166]. A triplex DNA binder such as 
naphthylquinoline was utilized by Gothelf and colleagues to successfully form the parallel pyrimidine–
purine–pyrimidine triplex 88 (Figure 15). Given the variety of small molecules available as potential 
DNA binders, the scope of this methodology may be expanded to include other template-directed 
transformations where conformational control is favorable. 
Figure 15. Representatives of other click-conjugated derivatives. 
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El-Sagheer used click chemistry to ligate two complementary DNA strands to produce an end-
sealed DNA duplex 89 (Figure 15) with a triazole-based linkage sealing each end of the duplex [39]. 
Each single strand had a 5′-terminal alkyne and 3′-azide. The CuAAC reaction was used to link the 
two strands by covalently joining the 5′-alkyne to the 3′-azide. The resultant constructs were thermally 
very stable and a fluorescent version remained intact for up to three days in fetal bovine serum. This Molecules 2012, 17  12692 
 
study illustrates the potential for these triazole end-sealed adducts as decoy protein ligands that can 
influence gene expression, or find utility in nanotechnology. 
In the interest of expanding the repertoire of triazole-modified nanomaterials, the CuAAC reaction 
was used to synthesize the first water-soluble container-shaped scaffold (cavitand) bearing four   
inter-locked triazole-linked guanosines (90, Figure 15) [167]. Sherman and colleagues used a cavitand-
shaped template functionalized with four progargyl ether rim groups and four pendant alkyl phosphate 
monoesters, serving as precursors for the four-fold click-cyclization with 5′-azido-5′-deoxyguanosine. 
These compounds may potentially be used as assembly scaffolds for the template-driven construction 
of G-quadruplexes and other nano-scale structures and devices [168]. 
Finally, the Seela group has done extensive work which involves the cross-linking of   
single-stranded oligonucleotides using click chemistry [38,74,169–171]. These studies exemplify the 
use of alkynyl-modified nucleobases and bis-azides which undergo step-wise click-cyclyzation to form 
triazole-linked DNA-based adducts. Recently, Seela and colleagues investigated the attributes of the 
DNA cross-linking process through the CuAAC reaction [38]. They synthesized 7-deaza-alkynylated 
purine analogues or the corresponding C5-substituted pyrimidine nucleoside analogues, which were 
specifically incorporated within synthetic duplex oligonucleotides (91). Cross-linking was performed 
using the “bis-click” protocol between an acetylene-modified duplex and the bis-azide linkage 92, 
resulting in the chemoselective formation of interstrand cross-linked DNA molecules (93, Scheme 16). 
It was shown that interstrand cross-linked heterodimeric DNA duplexes were stabilized by the 
resultant cross-linkage. 
Scheme 16. “Bis-click” cross-linking of duplex DNA. 
 
3. Conclusions  
It is clearly evident that the field of functionalizing nucleic acids for their application in biological 
systems or for the development of novel nanomaterials holds a promising future. In the pursuit of 
finding reactions that can perform simple high-yielding transformations to nucleic acids which deviate 
from the traditional methods of modification, the Cu(I)-catalyzed version of the Huisgen [3 + 2] 
cycloaddition satisfies all necessary criteria as an indispensable tool. With the knowledge that azides Molecules 2012, 17  12693 
 
and alkynes are selectively reactive with each other under a variety of mild or harsh conditions 
resulting in a stable 1,4-regioisomer of the triazole heterocycle, the CuAAC provides a flexible 
medium through which nucleic acids can be directly modified. Whether the goal is the creation of 
novel biopolymers, PCR templates, bioconjugated superstructures, gene-silencing or antiviral agents, 
the possibilities presented by this modular transformation are endless when considering the number of 
modifiable sites on natural nucleosides. 
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